Showing 851-860 of 5314 results for "".
Bellafill Fills a Niche; Soolantra Targets Rosacea
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-bellafill-fills-a-niche-soolantra-targets-rosacea-/18995/In this edition of DermWireTV from the editors of Practical Dermatology® magazine, a look at the approval of Bellafill (Suneva) to treat acne scars and Soolantra (Ivermectin 1%, Galderma) to treat rosacea. Plus, Benzac (Galderma) is now available OTC to treat acne, and Opdivo (Bristol-Myers Squibb)Understanding Male Aesthetics
https://practicaldermatology.com/topics/practice-management/understanding-male-aesthetics/19118/As the male aesthetic market continues to grow, dermatologists need to understand aesthetic differences between men and women and recognize how these will influence treatment decisions. Terrence Keaney, MD talks about Botox and neurotoxins, dermal fillers, and lasers used to treat men.Alma Lasers Soprano ICE
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/alma-lasers-soprano-ice/19242/Soprano ICE is the next generation hair removal laser from Alma Lasers. With Alma Lasers' patented SHR technology, the new ICE offers pain free hair removal.IDAS, LBO Laser System by Quantel Derma
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/idas-lbo-laser-system-by-quantel-derma/19373/IDAS by Quantel Derma - Green Light for Mobile Power. IDAS is the powerful LBO laser system with 532 nm wavelength for vascular indications such as rosacea or telangiectasia and pigmented skin changes. Its 8 watt power make treatments very effective. Due to its robust technology, IDAS has an officiaHoya ConBio - Non-ablative Skin Rejuvination for Wrinkles and Acne Scars
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/hoya-conbio-non-ablative-skin-rejuvination-for-wrinkles-and-acne-scars/19459/A study with Dr. Paul Friedman reveals why the Medlite C6 is fast becoming the laser of choice for skin renewal. How to use the Medlite is discussed and demonstrations are shown.Masterclasses in Dermatology: The Importance of Interdisciplinary Teaching
https://practicaldermatology.com/conferences/masterclasses-in-dermatology-2025/masterclasses-in-dermatology-the-importance-of-interdisciplinary-teaching/33021/Masterclasses in Dermatology 2025 course directors Alice Gottlieb, MD, a dermatologist and rheumatologist at Mount Sinai, and Joseph Merola, MD, MMSc, chair and professor of dermatology at UT Southwestern Medical Center in Dallas, talk about the value of interdisciplinary education and collaborationRecap of Maui Derm Hawaii Meeting
https://practicaldermatology.com/series/dermwire-tv/recap-of-maui-derm-hawaii-meeting/32717/In this week's DermwireTV, key stakeholders in dermatology gather in Hawaii to discuss the latest developments and advances; a new review examines whether IgE-targeting therapies could represent a new treatment avenue for psoriasis and atherosclerosis; and the founder of SEEN hair care joSkin-vincible: A Children's Book for Living with Ichthyosis
https://practicaldermatology.com/topics/rare-disease/skin-vincible-a-childrens-book-for-living-with-ichthyosis/20260/Drs. Andrea Rustad, a graduate of the Northwestern University Feinberg School of Medicine and incoming dermatology resident at the University of Wisconsin, and Amy Paller, chair of the department of dermatology at the Northwestern Feinberg School of Medicine in Chicago, talk with Practical DermatoloPigmentation: Melasma vs. Postinflammatory Hyperpigmentation
https://practicaldermatology.com/conferences/maui-derm-2024/pigmentation-melasma-vs-hyperpigmentation-vitiligo-treatments-and-full-spectrum-photo-protection/20247/Chief Medical Editor Neal Bhatia, MD and Pearl Grimes, MD, discuss Dr. Grimes’ presentations on pigmentation, including the difference between melasma and postinflammatory hyperpigmentation, and the importance of photo-protection in darker skin types.Changing Approaches to Diagnosis and Research: DermTech's Contributions
https://practicaldermatology.com/topics/skin-cancer-photoprotection/changing-approaches-to-diagnosis-and-research-dermtechs-contributions/20137/John Dobak, MD, President/CEO of DermTech discusses the addition of the company's melanoma test to the National Comprehensive Cancer Network guidelines. He talks about the future of clinical trials, especially the role of genomics for identifying trial participants and allowing more precise analysis